Suchergebnisse - "de Azambuja, E"

PubPharm (11)

1

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases : a systematic review and meta-analysis

enthalten in: ESMO open | 2022

von Nader-Marta, G. | Martins-Branco, D. | Agostinetto, E. | +7

2

How we treat patients with metastatic HER2-positive breast cancer

enthalten in: ESMO open | 2022

von Nader-Marta, G. | Martins-Branco, D. | de Azambuja, E.

3

Beta-blockers in early-stage breast cancer : a systematic review and meta-analysis

enthalten in: ESMO open | 2021

von Caparica, R. | Bruzzone, M. | Agostinetto, E. | +4

4

CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer : a systematic review and meta-analysis

enthalten in: ESMO open | 2021

von Agostinetto, E. | Vian, L. | Caparica, R. | +5

5

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Brandão, M. | Caparica, R. | Eiger, D. | +1

6

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination : A meta-analysis of randomized controlled trials

enthalten in: Cancer treatment reviews | 2017

von Solinas, C. | Ceppi, M. | Lambertini, M. | +9

7

Guidelines for time-to-event end point definitions in breast cancer trials : results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Gourgou-Bourgade, S. | Cameron, D. | Poortmans, P. | +42

ErratumIn: Ann Oncol. 2015 Dec;26(12):2505-6. - PMID 26467471

8

Hurdles and delays in access to anti-cancer drugs in Europe

enthalten in: Ecancermedicalscience | 2014

von Ades, F. | Zardavas, D. | Senterre, C. | +5

9

Pertuzumab : new hope for patients with HER2-positive breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Capelan, M. | Pugliano, L. | De Azambuja, E. | +5

10

Long-term toxic effects of adjuvant chemotherapy in breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Azim, H. | de Azambuja, E. | Colozza, M. | +2